Royal Pharmaceutical Society (RPS) - News updates

Certain pages on this news feed are only available to RPS members and hence requires members to log-in accordingly

RPS England welcomes Government review of polypharmacy

Commenting on the proposed review of polypharmacy ordered by the Health and Social Care Secretary, Chair of the English Pharmacy Board Sandra Gidley said: ‘’Pharmacists across the health

We welcome recognition of pharmacists supporting access to medicines

Making sure pharmacists are able to provide patients with the medicines they need is our priority. Pharmacists are already helping patients to get hold of medicines in short supply every day. We ar

Patient Safety Alert: Safer temporary identification criteria for unknown or unidentified patients

NHS Improvement has issued a patient safety alert for the safer temporary identification criteria for unknown or unidentified patients for all organisations with emergency departments.

Class 2 Medicines Recall: Teva UK Limited and Mylan - recall of some Valsartan containing products

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a precautionary recall of all affected batches of Valsartan containing medicines made by Mylan and Teva UK Limited. This is du

Prescribing Gluten-Free Foods in Primary Care: Guidance for CCGs

Supporting guidance for the prescribing of gluten-free foods in Primary Care has been issued by NHS England.

Medicines and a no-deal Brexit

The UK imports 37 million packs of medicine each month from the EU - and exports even more. RPS President Ash Soni was interviewed today about access to medicines in case ofa no-deal Brexit on the BB

Update on adrenaline auto-injectors

The interim protocol on dispensing of adrenaline auto-injectors, 150microgram will no longer be in effect from Thursday 29th November 2018.

Rapid response teams welcomed by RPS England

Responding to the announcement today from the Department of Health and Social Care that ‘community-based rapid response teams’ and dedicated support for care home residents will involve ph

Avastin: updated statement on its use for the treatment of wet AMD

The recent judicial review ruling finds the use of Avastin (bevacizumab) in the NHS for the treatment of wet AMD to be lawful. Whilst we recognise the financial savings that could be made by switching

Additional guidance to clinicians: Cannabis-based products for medicinal use

NHS England has published additional guidance to clinicians: Cannabis-based products for medicinal use, which is endorsed by the Scottish Government, Department of Health Northern Ireland and Welsh Go